“…There were 10 cohort studies [ 12 , 28 , 29 , 39 , 51 , 58 , 98 , 99 , 100 , 101 ] and 18 case studies [ 60 , 93 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 ] that described 77 (54 from cohort studies, 23 from case studies) patients with an intermediate form of ZSD. In the cohort studies, the prevalence of seizures (51.0%, out of n = 51), brain abnormalities (15.4%, out of n = 26), hypotonia (97.6%, out of n = 41), reduced mobility (70.8%, out of n = 24), feeding difficulties (52.9%, out of n = 17), abnormal liver function or structure (79.0%, out of n = 38), adrenal insufficiency (57.1%, out of n = 28), and hearing loss (57.1%, out of n = 28) was significantly greater in the intermediate category compared to the mild category ( p ≤ 0.011, Table 1 ).…”